ANTH
Anthera Pharmaceuticals, Inc.
ANTH
ANTH
Delisted
ANTH was delisted on the 27th of June, 2018.
60 hedge funds and large institutions have $11.1M invested in Anthera Pharmaceuticals, Inc. in 2017 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 20 increasing their positions, 14 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
60
Holders Change
-12
Holders Change %
-16.67%
% of All Funds
1.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
20
Reduced
14
Closed
16
Calls
$12K
Puts
$102K
Net Calls
-$90K
Net Calls Change
-$17K
Top Buyers
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$3.4M |
| 2 |
BlackRock
New York
|
+$1.23M |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
+$709K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$391K |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$390K |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.19M |
| 2 |
A
Abingworth
London,
United Kingdom
|
-$1.17M |
| 3 |
Millennium Management
New York
|
-$119K |
| 4 |
RFCA
R&F Capital Advisors
New York
|
-$111K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
-$99.5K |
